everydayhealth.com
IBD Leads to Financial Sacrifices, Survey Shows — 5 Ways to Manage Costs Now
The article reports that many people with IBD face unaffordable care and medication access problems that can lead to nonadherence and worse health. It offers practical steps to manage costs now and calls for policy changes to improve access.
Adults with IBD, people taking biologics or specialty meds, caregivers, and clinicians who support patients with medication access and financial-assistance navigation.
What To Know
What to know This article summarizes results from a Crohn’s & Colitis Foundation survey reporting that many people with IBD face high out-of-pocket costs and make financial sacrifices (skipping essentials, increasing debt, delaying care). It highlights that cost-related medication access problems were common and sometimes led to worsened health.
The piece includes one patient story about prior intestinal surgery and lists practical steps patients can take now: check financial assistance programs, understand insurance benefits, negotiate medical bills, consider generics/biosimilars with a clinician, and use copay-accumulator resources.
Why it matters High costs can affect whether people fill or stick with IBD medicines, which can worsen disease and quality of life. The article points to both individual strategies and the need for broader policy reforms that could lower barriers to care.
Who should pay attention Adults living with IBD (Crohn’s disease or ulcerative colitis), people on biologic or specialty medications, caregivers, and clinicians who help patients navigate treatment costs or financial-assistance resources.
More context The piece is primarily an interpretation of a foundation survey and advocacy viewpoint, not a clinical study. Recommendations are practical, not clinical guidance; patients should discuss medication changes (including switching to generics or biosimilars) with their clinician.
The article advocates for policy reforms but does not present new clinical data.
Findings are drawn from a Crohn’s & Colitis Foundation survey and framed as advocacy; this is not new clinical research. Practical tips (assistance programs, insurance navigation, copay-accumulator tools) are intended to help but should be discussed with a clinician or benefits advisor before changing treatment.
